Literature DB >> 23044875

WNT4, RSPO1, and FOXL2 in sex development.

Anna Biason-Lauber1.   

Abstract

The idea that the female sexual development happens by default was born in the middle of the last century after Jost performed his innovative experiments to study the bases of differentiation of the reproductive tract and found that the female reproductive tract develops even in the absence of any gonad. The term default (passive) attributed to the whole female developmental pathway, therefore, established itself, even if it was not originally so intended. However, recent developments have demonstrated that ovarian development is an active process. Wingless type MMTV integration site family, member 4 (WNT4), one of a few factors with a demonstrated function in the ovarian-determination pathway, has been found to be involved in sexual differentiation by suppressing male sexual differentiation, promoting Müllerian duct differentiation, and maintaining oocyte health. WNT4 expression in the ovary seems to be regulated by R-spondin 1 (RSPO1), a thrombospondin family member protein. The role and interactions of WNT4, RSPO1, and other factors such as forkhead transcription factor 2 in ovarian development and function will be discussed. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23044875     DOI: 10.1055/s-0032-1324722

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  18 in total

Review 1.  Pituitary gland development and disease: from stem cell to hormone production.

Authors:  Shannon W Davis; Buffy S Ellsworth; María Inés Peréz Millan; Peter Gergics; Vanessa Schade; Nastaran Foyouzi; Michelle L Brinkmeier; Amanda H Mortensen; Sally A Camper
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

2.  Intrinsic disorder in spondins and some of their interacting partners.

Authors:  Oluwole Alowolodu; Gbemisola Johnson; Lamis Alashwal; Iqbal Addou; Irina V Zhdanova; Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2016-12-15

3.  Genome-wide identification of CBX2 targets: insights in the human sex development network.

Authors:  Wassim Eid; Lennart Opitz; Anna Biason-Lauber
Journal:  Mol Endocrinol       Date:  2015-01-08

Review 4.  Disorders of sex development.

Authors:  Selma Feldman Witchel
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2017-11-22       Impact factor: 5.237

5.  Isolation and Characterization of Germline Stem Cells in Protogynous Hermaphroditic Monopterus albus.

Authors:  Xiaoyun Sun; Binbin Tao; Yongxin Wang; Wei Hu; Yuhua Sun
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

6.  Whole-genome sequence analysis reveals selection signatures for important economic traits in Xiang pigs.

Authors:  Xiying Wang; Xueqin Ran; Xi Niu; Shihui Huang; Sheng Li; Jiafu Wang
Journal:  Sci Rep       Date:  2022-07-12       Impact factor: 4.996

Review 7.  Translational genetics for diagnosis of human disorders of sex development.

Authors:  Ruth M Baxter; Eric Vilain
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-07-15       Impact factor: 8.929

Review 8.  Genetic regulation of mammalian gonad development.

Authors:  Stefanie Eggers; Thomas Ohnesorg; Andrew Sinclair
Journal:  Nat Rev Endocrinol       Date:  2014-09-23       Impact factor: 43.330

9.  Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus.

Authors:  Dylan M Glubb; Tracy A O'Mara; Pik Fang Kho; Sally Mortlock; Peter A W Rogers; Dale R Nyholt; Grant W Montgomery; Amanda B Spurdle
Journal:  Hum Genet       Date:  2021-07-15       Impact factor: 4.132

Review 10.  WNT4 Balances Development vs Disease in Gynecologic Tissues and Women's Health.

Authors:  Lauren M Pitzer; Marisa R Moroney; Natalie J Nokoff; Matthew J Sikora
Journal:  Endocrinology       Date:  2021-07-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.